[ information below provided courtesy of Amanda Boxtel ]

Based in Delhi, India, Dr. Geeta Shroff operates out of two hospitals:• The original Nu Tech Mediworld hospital based in Gautam Nagar, Delhi is a 20-bed facility• A brand new five-story, 20-bed hospital located in Green Park Extension, Delhi (which is approximately five minutes by vehicle from the original hospital).Dr. Shroff’s Embryonic Stem Cell TechnologyDr. Shroff is an infertility expert and she is the very first individual to develop an infinite number of pure human embryonic stem cell lines fromusing just one embryo. Her partnering physician and anesthesiologist is Dr. Ashish Verma.Dr. Shroff’s treatment is ground breaking. Every day we hear about other treatments around the globe regarding stem cells (fetal, umbilical cord, nasal, rats, mice etc.) and Dr. Geeta Shroff has developed the only purely human embryonic stem cell lines that do not show any immune reaction in the body. Embryonic stem cells do not have any antigenic proteins on their surface and thus do not require immunosuppressant drugs. Dr. Shroff’s technology involved the use of just ONE embryo. During her laboratory research she only used surplus embryos from an IVF donor who underwent a barrage of tests including a complex medical history and genetic history.I (Amanda Boxtel) will provide my best explanation of Dr. Shroff’s HESC Treatment below.The text is partially extracted from Dr. Shroff’s book Human Embryonic Stem Cells: A Revolution in Therapeutics. In the laboratory, the sperm fertilizes an egg, which then becomes a zygote. These stem cells have the highest degree of plasticity and can develop into any cell, not only into an embryo, but also the surrounding tissues, such as the placenta. The term used to refer to these stem cells is totipotent. Thirty hours after an ovum is fertilized, the zygote begins to divide. By the fifth or sixth day, the cells form a blastocyst. These stem cells are somewhat less plastic and more specialized than the zygote. Those on the outer surface of the blastocyst develop into the placenta and other tissues that surround the fetus, while those inside, referred to as embryonic stem cells, become the cells of all the fetal organs and tissues. Such stem cells can differentiate into any of the more than 200 types of cells in the body and are referred to as pluripotent. The embryonic stem cells do not show any immune reaction as they do not have antigenic proteins on their surface. They also are able to multiply rapidly.Dr. Shroff’s revolutionary and highly secretive technology enabled her to develop a method to extract these embryonic stem cells and create stem lines in a totally pure human product. An example of a stem line created in the lab is a neuronal (nerve cell) stem line. A patient with a neuronal disorder affecting the brain, spinal cord, or nerves would be administered neuronal embryonic stem cells from a neuronal stem line. Stem lines created in the lab have homing-in capabilities so that once they are injected into the body, they home-in to the injury site, or damaged cells that need repair.When injected, HESCs can repair the affected area in addition to restoring the physiological functions of the affected area. HESCs have no capacity to fully form a new organ. Once HESCs are injected into a patient, the division of the HESCs is finite, which means over a period of time uncontrolled division is not going to form tumors. Over five years of treatment, Dr. Shroff and Dr. Ashish Verma have not found any negative side effects in their patients. In simple terms it can be said that the complete effect of HESCs transplanted into a patient is closely linked with the time frame of the human embryo’s development. This is including nine months of gestation; and then the growth of a new born baby after delivery up until five years of age. After the baby is delivered, the functioning capacity gradually increases as it would in a growing child. Milestones take place in a newborn growing into an infant and critical functions are required for the child to progress such as environmental factors, physical (motor) factors, and educational factors (learned mental development). Although response results in patients are seen immediately after transplantation, the embryonic stem cells continue their developmental process as per their pre-programmed time frame.In my case scenario, I might be experiencing slight changes in my body now, but as the stem cells “home in” to the injury site in my body, they differentiate and fire up the affected tissue and their neurons find new pathways to reconnect the synapses and the damaged tracts. I will have to be patient with my treatment in that I may not see results for several months or even two-to-five years down the road.All of Dr. Shroff’s patients generally become healthier and suffer fewer bouts of infection. Their body resistance to infection increases. The earlier a patient starts the human embryonic stem cell therapy, the faster the chances are for recovery (I have 15 years to work on as opposed to others who are more newly injured). In progressive and degenerative disorders the early start on stem cell therapy helps in stemming the disease or stabilizing the patient. Once stabilized, patients do show improvement.Every patient I met in the course of my two month stay showed improvement of some sort. In addition to showing improvement, amazingly, people looked younger. A Parkinson’s patient named David from Perth, Australia, grew dark eyebrows in three weeks; his eyes became sparkly; and his speech came back with a thick English accent, which his care giver hadn’t heard in sixteen years. It was simply remarkable to roll into the hospital everyday and exchange stories on what muscle or body part was beginning to function again… something unheard of until my visit to Nu Tech Mediworld in India. I witnessed three patients suffering from motor neuron disease (like ALS) and had been given a few months to live. With all three patients, they are stable, their condition isn’t worsening, and they are seeing slight improvements (regaining speech, strength, breathing capacity etc).I met many other patients from around the globe. Several were from Australia, three families were from Hong Kong, and other families came from Iran, Saudi Arabia, Kuwait, Egypt, and Korea. The patients’ illnesses or disabilities ranged from Spinal Cord Injuries; Parkinsons; Stroke/Alzheimers; Motor Neuron Disease/ALS; to Diabetes/blind. Some of Dr. Shroff’s other Indian patients suffer from Cerebral Palsy, autism, heart conditions, traumatic brain injuries, and cancer to name a few.It should be known that Dr. Shroff seeks no financial gain from her treatment beyond her hard financial costs. US $30,000 for a two month treatment (which included accommodations for me and a care giver) is appropriate given the cost of medical treatment around the world. It should also be stated that Dr. Shroff provides free treatment to the majority of her Indian patients (80% approx.) who have absolutely no money. I am not sure if she has a scholarship program with a sliding scale in place… or if Dr. Shroff might consider this option for future patients residing outside India.The human embryonic stem cell treatment has been used in a number of conditions in clinical trials. All have shown progress of some kind. To name a few: Autism; mental retardation; liver disorders; degenerative nervous system disorders: alzheimers, parkinsons, multiple sclerosis, motor neuron disease/ALS; cerebral palsy; traumatic brain injuries; various skin disorders; auto immune disorders—lupus; genetic disorders—down syndrome etc.; eye disorders; kidney disorders; musculoskeletal disorders—Duchenne’s muscular dystrophy etc.; spinal cord injuries; and cardiacpatients.Counter to research and opinions worldwide, Dr. Shroff’s technology avoidscontroversial and ethical issues:By using ONLY one human embryo to create innumerable stem lines that are pure, thus negating the use and destruction of many human embryos; cloning procedures; or the use of any animal stem cells such as those found in mice or rats. Human embryonic stem cells do not create any immune reaction in the body, as they do not have any antigenic proteins on their surface. This negates the need for immunosuppressant drugs. Human embryonic stem cells have the highest degree of plasticity and are ‘pluripotent’ meaning they have the capability to differentiate into any of the more than 200 types of cells in the human body (including all blood types). Both fetal stem cells and adult stem cells under the right circumstance can be pluripotent if they are derived from the donor’s own body. The possible challenges of immune reactivity make these cells impossible to be used in auto-immune disorders.To my knowledge Dr. Shroff is the only person in the world who has conducted successful clinical applications on humans since the year 2002 on over 300 patients suffering from incurable ailments with zero adverse reactions. Dr. Shroff has filed for a patent in both India and the United States, which covers 126 countries. It is out of her hands and she is waiting for their response.With my layperson’s understanding, part of Dr. Shroff’s battle with medical communities andworldwide pharmaceutical companies comes down to the financial factor of those companieslosing money. Billions of dollars are spent with drugs to band-aid treatments, and Dr. Shroffhas the ultimate cure for many illnesses. Dr. Shroff does not claim to be an expert in every fieldbut has specialized in infertility and stem cell treatment. She is a humble yet brilliant individual who will not allow such adversities to affect either her or her mission.I encourage you to do your own research, see with your own eyes, and you too will be amazed by what is happening. I and many others are living proof that her treatment is working!